Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Neoplasm — Research · CancerIndex

Cancers
Neoplasm

Cancer Family

Neoplasm

CI-CAN-00000001Explore in graph →

Non-malignant22,971 active trials259 approved drugs4,031 evidence items

NCIt: C3262
MeSH: D009369

Overview
Statistics
Survival
Genomics495
Variants & evidence4031
Drugs435
Trials105884
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (4,505)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 4,201–4,225 of 4,505 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Targeting Akt3 signaling in triple-negative breast cancer.
· Cancer Res · 2014 · PMID 24335962 · validated civic_curation pubmed
The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.
· Mol Cancer Ther · 2012 · PMID 22302096 · validated civic_curation pubmed
Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.
· Cancer · 2012 · PMID 22252991 · validated civic_curation pubmed
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.
· Cell · 2010 · PMID 20141835 · validated civic_curation pubmed
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients.
· Clin Cancer Res · 2000 · PMID 11051239 · validated civic_curation pubmed
The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns.
· Blood · 2019 · PMID 31434706 · validated civic_curation pubmed
Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia.
· Blood Cancer J · 2014 · PMID 24927407 · validated civic_curation pubmed

Showing 4,201–4,225 of 4,505 publications

← Previous
1
…
168
169
170
…
181
Next →

Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.

· Am J Pathol · 2013 · PMID 23506848 · validated civic_curation pubmed

Epiregulin is required for lung tumor promotion in a murine two-stage carcinogenesis model.

· Mol Carcinog · 2017 · PMID 26894620 · validated civic_curation pubmed

An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model.

· Genes Dev · 2016 · PMID 27034505 · validated civic_curation pubmed

Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.

· Oncotarget · 2015 · PMID 25970771 · validated civic_curation pubmed

ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.

· Mol Cancer Res · 2014 · PMID 24296758 · validated civic_curation pubmed

Circadian regulation of mTOR by the ubiquitin pathway in renal cell carcinoma.

· Cancer Res · 2014 · PMID 24253377 · validated civic_curation pubmed

Association between PD-L1 expression and driven gene status in NSCLC: A meta-analysis.

· Eur J Surg Oncol · 2017 · PMID 28259530 · validated civic_curation pubmed

Primary and Metastatic Melanoma With NTRK Fusions.

· Am J Surg Pathol · 2018 · PMID 29683819 · validated civic_curation pubmed

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.

· Cancer Discov · 2018 · PMID 29196463 · validated civic_curation pubmed

A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivity.

· Amino Acids · 2014 · PMID 24658966 · validated civic_curation pubmed

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.

· Mol Cancer Res · 2009 · PMID 19737969 · validated civic_curation pubmed

Martelotto et al. J Pathol 2015

· 2015 · PMID 26095796 · validated cbioportal_study pubmed

Allen et al. J Clin Invest 2019

· 2019 · PMID 31483290 · validated cbioportal_study pubmed

Ross et al. Am J Surg Pathl 2014

· 2014 · PMID 24418857 · validated cbioportal_study pubmed

Rettig et al, Cancer Prev Res 2016

· 2016 · PMID 26862087 · validated cbioportal_study pubmed

Mitani et al. Clin Cancer Res 2015

· 2015 · PMID 26631609 · validated cbioportal_study pubmed

Drier et al. Nature Genetics 2016

· 2016 · PMID 26829750 · validated cbioportal_study pubmed

Ho et al. Nat Genet 2013

· 2013 · PMID 23685749 · validated cbioportal_study pubmed